Cart
sales@molnova.com
Home - Products - Tyrosine Kinase - CSF1R - cFMS Receptor Inhibitor IV

cFMS Receptor Inhibitor IV

CAS No. 959626-45-0

cFMS Receptor Inhibitor IV( 5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide )

Catalog No. M28536 CAS No. 959626-45-0

cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 282 Get Quote
25MG 480 Get Quote
50MG 691 Get Quote
100MG 972 Get Quote
500MG 1944 Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    cFMS Receptor Inhibitor IV
  • Note
    Research use only, not for human use.
  • Brief Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • Description
    cFMS Receptor Inhibitor IV is an inhibitor of c-Fms tyrosine kinase.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-cyano-N-(2,5-di(piperidin-1-yl)phenyl)furan-2-carboxamide
  • Pathway
    Tyrosine Kinase
  • Target
    CSF1R
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    959626-45-0
  • Formula Weight
    378.47
  • Molecular Formula
    C22H26N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 31.25 mg/mL (82.57 mM)
  • SMILES
    N#CC=1OC(=CC1)C(=O)NC2=CC(=CC=C2N3CCCCC3)N4CCCCC4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • JNJ-28312141

    JNJ-28312141 is a potent, orally active CSF-1 receptor (CSF-1R) kinase inhibitor with IC50 of 0.69 nM.

  • Emactuzumab

    Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.

  • Plonmarlimab

    Plonmarlimab (TJ003234) is an anti-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody with potential antiviral activity for the study of immune diseases and novel coronavirus infections.

Sign In Join Free